<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Another Quarter of Healthy Growth: Q221 Trauma Market Recap

9/22/21 4:00 PM

Q221 Trauma Header FINALTrauma market rebounds as top segments drive growth amid easy YoY comps

The Trauma Market experienced another quarter of healthy growth as the WW and US Trauma Markets ended Q221 up YoY compared to Q220.  Looking forward to Q321, SmartTRAK feels that trauma procedures will likely not be as heavily impacted by the rise in the Delta variant as its elective procedure counterparts. We will continue to monitor the situation as the variant impacts states, as recently observed in Texas.

Among the many topics covered in detail in our comprehensive Q221 Trauma Market Recap* are:

  • Complete Q221 Trauma Market Overview
  • SmartTRAK's Expert Analysis and Insights
  • All Trauma Market News including Revenues, Data, Charts and Shares
  • IM Nails Are Back on Top
  • New Developments in Plates & Screws
  • Q221 IM Nailing & Plates and Screws Patents
  • Regulatory Highlights

Historically one of the largest Trauma segments, Q221 saw IM Nails touted as a driving force for major trauma players. US IM Nail market leader, Stryker (45.8% Q2 US share), commented that while its US business benefited from COVID-19 recovery as well as the ongoing execution of the Wright US sales integration, its US Trauma & Extremities business experienced ...

Read the entire Q221 Trauma Market Recap, including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More

SmartTRAK has recently launched five new modules for 2021, including Arthroscopic TechnologiesPediatric Extremities, Pediatric Spine and Pediatric Trauma. Click here to see details of the exciting new content now available on SmartTRAK.


Natasha Weeks
Written by Natasha Weeks

13 years' experience in marketing and product development, including 5+ years at DePuy Synthes Trauma - most recently as Product Director at DePuy Synthes Trauma.

    Follow Us on Social Media

    Recent Articles